Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Financing Activities (2024 - 2025)

Historic Cash from Financing Activities for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$8000.0.

  • Pyxis Oncology's Cash from Financing Activities fell 10048.34% to -$8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $59.3 million for FY2024, which is 90060.72% up from last year.
  • Latest data reveals that Pyxis Oncology reported Cash from Financing Activities of -$8000.0 as of Q3 2025, which was down 10048.34% from $50000.0 recorded in Q4 2024.
  • Over the past 5 years, Pyxis Oncology's Cash from Financing Activities peaked at $57.5 million during Q1 2024, and registered a low of -$8000.0 during Q3 2025.